Current status of treatment for 2019 novel coronavirus pneumonia / 中华微生物学和免疫学杂志
Chinese Journal of Microbiology and Immunology
;
(12): E002-E002, 2020.
Article
in Chinese
| WPRIM
| ID: wpr-811596
ABSTRACT
2019 novel coronavirus (2019-nCoV) is a new member of coronavirus family that can cause serious respiratory diseases after the emergence of severe acute respiratory syndrome-coronavirus (SARS-CoV) and middle east respiratory syndrome-coronavirus (MERS-CoV). At present, there is no specific antiviral drug targeting 2019-nCoV. In facing of the increasingly serious epidemic of 2019 novel coronavirus pneumonia and the urgent needs in drug treatment strategies, this paper reviewed the current research situation and progress in antiviral treatment for the newly identified disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Microbiology and Immunology
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS